APA

Furet P., Masuya K., Kallen J., Stachyra-Valat T., Ruetz S., Guagnano V., Holzer P., Mah R., Stutz S., Vaupel A., Chène P., Jeay S. & Schlapbach A. (20170717). Discovery of a novel class of highly potent inhibitors of the p53-MDM2 interaction by structure-based design starting from a conformational argument. : Bioorganic & medicinal chemistry letters.

Chicago

Furet Pascal, Masuya Keiichi, Kallen Joerg, Stachyra-Valat Thérèse, Ruetz Stephan, Guagnano Vito, Holzer Philipp, Mah Robert, Stutz Stefan, Vaupel Andrea, Chène Patrick, Jeay Sébastien and Schlapbach Achim. 20170717. Discovery of a novel class of highly potent inhibitors of the p53-MDM2 interaction by structure-based design starting from a conformational argument. : Bioorganic & medicinal chemistry letters.

Harvard

Furet P., Masuya K., Kallen J., Stachyra-Valat T., Ruetz S., Guagnano V., Holzer P., Mah R., Stutz S., Vaupel A., Chène P., Jeay S. and Schlapbach A. (20170717). Discovery of a novel class of highly potent inhibitors of the p53-MDM2 interaction by structure-based design starting from a conformational argument. : Bioorganic & medicinal chemistry letters.

MLA

Furet Pascal, Masuya Keiichi, Kallen Joerg, Stachyra-Valat Thérèse, Ruetz Stephan, Guagnano Vito, Holzer Philipp, Mah Robert, Stutz Stefan, Vaupel Andrea, Chène Patrick, Jeay Sébastien and Schlapbach Achim. Discovery of a novel class of highly potent inhibitors of the p53-MDM2 interaction by structure-based design starting from a conformational argument. : Bioorganic & medicinal chemistry letters. 20170717.